Get the app Watchlists Portfolios Alerts Sign in Get started

Menu

Market-Moving News for October 14th

Benzinga Newsdesk Oct 14, 2024 2 years ago

MoversTrading Ideas

JSPR: 32% | Jasper Therapeutics shares are trading higher after the company announced it reported preliminary data from the Company's ongoing SPOTLIGHT Phase 1b/2a study of subcutaneous briquilimab in adult

JSPR: 32% | Jasper Therapeutics shares are trading higher after the company announced it reported preliminary data from the Company's ongoing SPOTLIGHT Phase 1b/2a study of subcutaneous briquilimab in adult participants with cold urticaria or symptomatic dermographism.

LFVN: 11% | LifeVantage shares are trading higher after the company announced the US launch of its MindBody GLP-1 System.

IVA: 177% | Inventiva Raises Up To €348M To Fund Phase 3 NATiV3 Clinical Trial For MASH, Appoints New Chairman and Director

Read the original